As coronavirus continues to have a significant impact on daily life in Europe, Fujifilm is leveraging its healthcare expertise and innovations to support efforts to counter COVID-19. From supplying front-line workers with the latest medical technologies that exploit the potential of artificial intelligence and aim to help save lives, to working with our partners to achieve the goal of delivering a safe and effective vaccine, Fujifilm Europe plays a unique role in helping to tackle this healthcare crisis.
As coronavirus continues to have a significant impact on daily life in Europe, Fujifilm is leveraging its healthcare expertise and innovations to support efforts to counter COVID-19. From supplying front-line workers with the latest medical technologies that exploit the potential of artificial intelligence and aim to help save lives, to working with our partners to achieve the goal of delivering a safe and effective vaccine, Fujifilm Europe plays a unique role in helping to tackle this healthcare crisis.
Building upon the company’s heritage in digital image processing technologies, Fujifilm’s SYNAPSE 3D is a leading visualization tool for diagnosis and clinical support decision-making. As the coronavirus pandemic takes a grip on physicians’ workload and time, this platform enables a faster and objective quantitative analysis of the onset of COVID-19 and supports radiologists in monitoring and studying the evolution of the disease.
For physicians working in critical care environments, mobile diagnostic technologies allow them to obtain immediate clinical information, whilst also improving patient safety, increasing efficiency, and decreasing complications. Fujifilm’s innovations in medical diagnostics, such as mobile X-ray and point of care ultrasound, are in the hands of professionals working on the front-line – and playing a vital role in patient care.
Photography – a foundation of Fujifilm’s business – continues to play an important role in documenting experiences through the pandemic. Instant photography is also performing a functional role for healthcare workers on the front-line, with instax instant cameras and films being donated so that medical staff can identify themselves on their personal protective equipment – and show their smiles to patients.
Fujifilm is now one of the world's leading providers of contract process development and manufacturing services for the biopharmaceutical sector and is playing an active role in supporting governments, academia and industry to rapidly scale up potential COVID-19 vaccines and therapies.
As a leader in the innovation and manufacture of cell culture media used in research and large-scale production of biotherapeutics, vaccines, cell and gene therapies, Fujifilm is supporting several key partners in their efforts to produce new therapies and vaccines in the battle against COVID-19.
As a potential pharmaceutical solution to the pandemic, the clinical application of Avigan (favipiravir) to treat COVID-19 is under study. Fujifilm has commenced a phase III clinical trial in Japan to assess the safety and efficacy of Avigan in COVID-19 patients with non-severe pneumonia, alongside a phase II clinical trial in the United States.
Contact Us
To get in touch with regard to any aspect of Fujifilm's work on helping fight COVID-19, please contact: news_feg@fujifilm.com
Fujifilm Healthcare Support in the times of Corona | Fujifilm
Although the current situation requires us to are supposed to keep a distance from each other, we at Fujifilm Healthcare are moving even closer together in a figurative sense right now.
Turbulent times require extraordinary measures. The Fujifilm Healthcare team continues to work at full capacity for you, so that you can continue to care for your patients with ease. Even in these difficult times, we are at your side as a competent partner.
#Fujifilm, #NeverStop Supporting #Healthcare.
Interview with Dr. Mangala Narasimhan on Responding to COVID-19 in New York.
Fujifilm Sonosite Chief Medical Officer Diku Mandavia, M.D. interviews Mangala Narasimhan, DO, a pulmonary and critical care specialist from Long Island Jewish Medical Center, part of Northwell Health in Long Island, New York. Dr. Narasimhan describes how the COVID-19 pandemic has impacted her hospital in the heart of New York's outbreak.
NEVER STOP TRANSFORMING OURSELVES AND THE WORLD
For more than 80 years, we've continued transforming ourselves. Building from our origins as a film company known for innovations like the world's first high ISO 400 film, we've evolved into a technology company working in areas such as healthcare, highly-functional materials, imaging solutions and more. By leveraging our advanced and unique technologies, we will continue creating value from innovation and contribute to solving social challenges. Which means we'll never stop building on our experience and expertise to help transform ourselves, and the world.
(Hero Photo at top page by Fusion Medical Animation on Unsplash)